Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma
Publication
, Other
Reddy, GB; Kerr, DL; Spasojevic, I; Tovmasyan, A; Hsu, DS; Brigman, BE; Somarelli, JA; Needham, D; Eward, WC
April 3, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Reddy, G. B., Kerr, D. L., Spasojevic, I., Tovmasyan, A., Hsu, D. S., Brigman, B. E., … Eward, W. C. (2023). Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. https://doi.org/10.1158/1535-7163.22520695
Reddy, Gireesh B., David L. Kerr, Ivan Spasojevic, Artak Tovmasyan, David S. Hsu, Brian E. Brigman, Jason A. Somarelli, David Needham, and William C. Eward. “Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma,” April 3, 2023. https://doi.org/10.1158/1535-7163.22520695.
Reddy GB, Kerr DL, Spasojevic I, Tovmasyan A, Hsu DS, Brigman BE, et al. Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 2023.
Reddy, Gireesh B., et al. Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 3 Apr. 2023. Crossref, doi:10.1158/1535-7163.22520695.
Reddy GB, Kerr DL, Spasojevic I, Tovmasyan A, Hsu DS, Brigman BE, Somarelli JA, Needham D, Eward WC. Supplementary Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 2023.